These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25756573)

  • 1. Early development of coronary artery aneurysms after implantation of biolimus-eluting stent with biodegradable polymer.
    Goldberg A; Zdorovyak A; Rosenfeld I; Nordkin I
    Int J Cardiol; 2015 Apr; 184():487-488. PubMed ID: 25756573
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical outcomes with 6 months dual antiplatelet therapy after implantation of biolimus-A9 drug eluting coronary stents.
    Cockburn J; Pareek N; Poliacikova P; Saraf S; Williams R; Dhillon G; Robinson D; Gerber R; Hatrick R; Blows L; de Belder A; Hildick-Smith D
    Int J Cardiol; 2014 Mar; 172(1):185-9. PubMed ID: 24462139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and blood flow find its way.
    Ketterer U; Polzin A; Kelm M; Zeus T
    Clin Res Cardiol; 2015 Jan; 104(1):89-91. PubMed ID: 25139523
    [No Abstract]   [Full Text] [Related]  

  • 4. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable pharmacokinetics of biolimus A9 after deployment of Nobori stent for coronary artery disease: insights from Nobori PK study in Japanese subjects.
    Nakamura M; Otsuka Y; Ueda Y; Mitsudo K
    Cardiovasc Interv Ther; 2012 Jan; 27(1):24-30. PubMed ID: 24122637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice.
    Klauss V; Serruys PW; Pilgrim T; Buszman P; Linke A; Ischinger T; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; van Geuns RJ; van Es GA; Kalesan B; Wenaweser P; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2011 Aug; 4(8):887-95. PubMed ID: 21851904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 8. Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation.
    Patil P; Sethi A; Kaul U
    Indian Heart J; 2014; 66(2):216-9. PubMed ID: 24814120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
    Christiansen EH; Jensen LO; Thayssen P; Tilsted HH; Krusell LR; Hansen KN; Kaltoft A; Maeng M; Kristensen SD; Bøtker HE; Terkelsen CJ; Villadsen AB; Ravkilde J; Aarøe J; Madsen M; Thuesen L; Lassen JF;
    Lancet; 2013 Feb; 381(9867):661-9. PubMed ID: 23374649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.
    Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation?
    Finn AV; Nakazawa G; Ladich E; Kolodgie FD; Virmani R
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):485-8. PubMed ID: 19356471
    [No Abstract]   [Full Text] [Related]  

  • 12. Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy.
    Wykrzykowska JJ; Räber L; de Vries T; Bressers M; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Regar E; Jüni P; Windecker S; Serruys PW
    EuroIntervention; 2009 Aug; 5(3):310-7. PubMed ID: 19736154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient coronary aneurysm formation after Nevo™ stent implantation versus persistent coronary aneurysm after Cypher Select™ stent implantation.
    Christiansen EH; Lassen JF; Jensen LO
    J Invasive Cardiol; 2011 Jul; 23(7):E158-60. PubMed ID: 21725130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery aneurysm formation after drug-coated balloon treatment of de novo lesions: Two case reports.
    Zhang HP; Yu X; Ji FS; Sun FC
    Medicine (Baltimore); 2018 Nov; 97(45):e13208. PubMed ID: 30407362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).
    Wykrzykowska J; Serruys P; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; Di Mario C; Van Geuns RJ; Van Es GA; Juni P; Windecker S
    EuroIntervention; 2011 Nov; 7(7):789-95. PubMed ID: 22027687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.
    Windecker S; Serruys PW; Wandel S; Buszman P; Trznadel S; Linke A; Lenk K; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Davies S; van Geuns RJ; Eerdmans P; van Es GA; Meier B; Jüni P
    Lancet; 2008 Sep; 372(9644):1163-73. PubMed ID: 18765162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.
    Roth C; Gangl C; Dalos D; Delle-Karth G; Neunteufl T; Berger R
    J Interv Cardiol; 2018 Dec; 31(6):780-791. PubMed ID: 30479028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery aneurysm following drug-coated balloon treatment.
    Solomonica A; Musallam A; Roguin A
    Cardiovasc Revasc Med; 2015 Dec; 16(8):505-7. PubMed ID: 26349442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of a giant unruptured mycotic coronary artery aneurysm after coronary angioplasty.
    Aggarwal P; Saxena P; Bhan A
    Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S44-S46. PubMed ID: 27751325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
    Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS
    Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.